Synthetic triterpenoids have cytotoxicity in pediatric acute lymphoblastic leukemia cell lines but cytotoxicity is independent of induced ceramide increase in MOLT-4 cells

[1]  A. Bielawska,et al.  Involvement of Dihydroceramide Desaturase in Cell Cycle Progression in Human Neuroblastoma Cells* , 2007, Journal of Biological Chemistry.

[2]  M. Cabot,et al.  Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. , 2006, Biochimica et biophysica acta.

[3]  A. Bielawska,et al.  The CLN9 Protein, a Regulator of Dihydroceramide Synthase* , 2006, Journal of Biological Chemistry.

[4]  M. Konopleva,et al.  The novel triterpenoid CDDO-Me suppresses MAPK pathways and promotes p38 activation in acute myeloid leukemia cells , 2005, Leukemia.

[5]  W-X Guo,et al.  N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes , 2002, Leukemia.

[6]  M. Cabot,et al.  N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase. , 2001, Cancer research.

[7]  M. Cabot,et al.  Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism. , 2000, Journal of the National Cancer Institute.

[8]  M. Sporn,et al.  Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages. , 1998, Bioorganic & medicinal chemistry letters.

[9]  W-X Guo,et al.  leu N-( 4-hydroxyphenyl ) retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines , but not to nonmalignant lymphocytes , 2002 .